BioCentury | Mar 2, 2015
Financial News

Neos Therapeutics completes venture financing

...Neurology Date completed: 2015-02-25 Type: Venture financing Raised: $20.6 million Investors: Presidio Partners; Crabtree Partners; CAC LLC...
BioCentury | Feb 13, 2006
Company News

Quidel board of directors update

...Appointed: Jack Schuler, former president and COO at Abbott Laboratories; and Rod Dammeyer, president of CAC LLC...
Items per page:
1 - 2 of 2
BioCentury | Mar 2, 2015
Financial News

Neos Therapeutics completes venture financing

...Neurology Date completed: 2015-02-25 Type: Venture financing Raised: $20.6 million Investors: Presidio Partners; Crabtree Partners; CAC LLC...
BioCentury | Feb 13, 2006
Company News

Quidel board of directors update

...Appointed: Jack Schuler, former president and COO at Abbott Laboratories; and Rod Dammeyer, president of CAC LLC...
Items per page:
1 - 2 of 2